The company’s innovations have not gone unnoticed. AI Medical Service was featured in 
SONIRE’s approach, which utilizes cavitation to enhance treatment accuracy, has been recognized by the U.S. FDA as a breakthrough device. The company is currently conducting a world-first randomized trial to further validate the efficacy of their technology. As CEO Satoh Tohru notes, the goal is to offer a more effective and safer cancer treatment to patients worldwide.
These Japanese startups are not only advancing medical technology but also providing hope for millions of cancer patients globally. As the world braces for a surge in cancer cases, innovations from companies like AI Medical Service and SONIRE Therapeutics could be pivotal in changing the landscape of cancer treatment.
Florida’s Insurance Crisis Explained: Why Coastal Risk Is Pushing the Market to Its Breaking Point
Florida’s insurance market is under intense pressure as millions of residents and trillions in property wealth cluster along hurricane‑vulnerable coastlines. This article breaks down how decades of growth in high‑risk zones created today’s crisis, why traditional pricing models can’t keep up, and what real estate and insurance professionals must do to stay ahead. It offers actionable insights on underwriting, risk communication, policy partnerships, and resilience planning—critical knowledge for anyone advising Florida homeowners or navigating the state’s evolving insurance landscape.
